Value of screening umbilical cord blood for hemoglobinopathy
Foremost among the beneficial effects of screening umbilical cord blood is the optimized quality of care that can follow the immediate involvement of an infant with sickle cell disease and his or her family in an appropriate health care system. This is exemplified by the reduction in the case fatali...
Gespeichert in:
| Veröffentlicht in: | Pediatrics (Evanston) 1989-05, Vol.83 (5 Pt 2), p.823-826 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 826 |
|---|---|
| container_issue | 5 Pt 2 |
| container_start_page | 823 |
| container_title | Pediatrics (Evanston) |
| container_volume | 83 |
| creator | Lobel, J S Cameron, B F Johnson, E Smith, D Kalinyak, K |
| description | Foremost among the beneficial effects of screening umbilical cord blood is the optimized quality of care that can follow the immediate involvement of an infant with sickle cell disease and his or her family in an appropriate health care system. This is exemplified by the reduction in the case fatality rate of pneumococcal septicemia that has been achieved. Appropriate follow-up of screening also includes transmission of information about the diagnosis of a hemoglobinopathy trait or alpha-thalassemia to affected families and their physicians, with ready availability of education and counseling. |
| doi_str_mv | 10.1542/peds.83.5.823 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78978362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78978362</sourcerecordid><originalsourceid>FETCH-LOGICAL-c288t-22bbda7683970a42141054fb97820237b44a8b1eda8a4316dffe8726a80ca61f3</originalsourceid><addsrcrecordid>eNo9kDtPwzAYAC0EKqUwMiJ5Ykv4_EjsSCyo4iVVYgFWy07sNsiJg50M_fekasV0y-mGQ-iWQE4KTh8G26RcsrzIJWVnaEmgkhmnojhHSwBGMg5QXKKrlH4AgBeCLtCCCiIYVEv0-K39ZHFwONXR2r7tt3jqTOvbWntch9hg40NosAsR72wXtj6Ytg-DHnf7a3ThtE_25sQV-np5_ly_ZZuP1_f10yarqZRjRqkxjRalZJUAzSnhBAruTCUkBcqE4VxLQ2yjpeaMlI1zVgpaagm1LoljK3R_7A4x_E42japrU229170NU1JCzilW0lnMjmIdQ0rROjXEttNxrwiowy11uKUkU4Wab83-3Sk8mc42__ZpD_sDDeJldw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78978362</pqid></control><display><type>article</type><title>Value of screening umbilical cord blood for hemoglobinopathy</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Lobel, J S ; Cameron, B F ; Johnson, E ; Smith, D ; Kalinyak, K</creator><creatorcontrib>Lobel, J S ; Cameron, B F ; Johnson, E ; Smith, D ; Kalinyak, K</creatorcontrib><description>Foremost among the beneficial effects of screening umbilical cord blood is the optimized quality of care that can follow the immediate involvement of an infant with sickle cell disease and his or her family in an appropriate health care system. This is exemplified by the reduction in the case fatality rate of pneumococcal septicemia that has been achieved. Appropriate follow-up of screening also includes transmission of information about the diagnosis of a hemoglobinopathy trait or alpha-thalassemia to affected families and their physicians, with ready availability of education and counseling.</description><identifier>ISSN: 0031-4005</identifier><identifier>EISSN: 1098-4275</identifier><identifier>DOI: 10.1542/peds.83.5.823</identifier><identifier>PMID: 2717309</identifier><language>eng</language><publisher>United States</publisher><subject>Anemia, Sickle Cell - blood ; Anemia, Sickle Cell - epidemiology ; Anemia, Sickle Cell - mortality ; Fetal Blood - analysis ; Hemoglobin SC Disease - blood ; Hemoglobin, Sickle - analysis ; Humans ; Infant, Newborn ; Mass Screening ; Ohio ; Sickle Cell Trait - blood ; Thalassemia - blood</subject><ispartof>Pediatrics (Evanston), 1989-05, Vol.83 (5 Pt 2), p.823-826</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c288t-22bbda7683970a42141054fb97820237b44a8b1eda8a4316dffe8726a80ca61f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2717309$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lobel, J S</creatorcontrib><creatorcontrib>Cameron, B F</creatorcontrib><creatorcontrib>Johnson, E</creatorcontrib><creatorcontrib>Smith, D</creatorcontrib><creatorcontrib>Kalinyak, K</creatorcontrib><title>Value of screening umbilical cord blood for hemoglobinopathy</title><title>Pediatrics (Evanston)</title><addtitle>Pediatrics</addtitle><description>Foremost among the beneficial effects of screening umbilical cord blood is the optimized quality of care that can follow the immediate involvement of an infant with sickle cell disease and his or her family in an appropriate health care system. This is exemplified by the reduction in the case fatality rate of pneumococcal septicemia that has been achieved. Appropriate follow-up of screening also includes transmission of information about the diagnosis of a hemoglobinopathy trait or alpha-thalassemia to affected families and their physicians, with ready availability of education and counseling.</description><subject>Anemia, Sickle Cell - blood</subject><subject>Anemia, Sickle Cell - epidemiology</subject><subject>Anemia, Sickle Cell - mortality</subject><subject>Fetal Blood - analysis</subject><subject>Hemoglobin SC Disease - blood</subject><subject>Hemoglobin, Sickle - analysis</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Mass Screening</subject><subject>Ohio</subject><subject>Sickle Cell Trait - blood</subject><subject>Thalassemia - blood</subject><issn>0031-4005</issn><issn>1098-4275</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kDtPwzAYAC0EKqUwMiJ5Ykv4_EjsSCyo4iVVYgFWy07sNsiJg50M_fekasV0y-mGQ-iWQE4KTh8G26RcsrzIJWVnaEmgkhmnojhHSwBGMg5QXKKrlH4AgBeCLtCCCiIYVEv0-K39ZHFwONXR2r7tt3jqTOvbWntch9hg40NosAsR72wXtj6Ytg-DHnf7a3ThtE_25sQV-np5_ly_ZZuP1_f10yarqZRjRqkxjRalZJUAzSnhBAruTCUkBcqE4VxLQ2yjpeaMlI1zVgpaagm1LoljK3R_7A4x_E42japrU229170NU1JCzilW0lnMjmIdQ0rROjXEttNxrwiowy11uKUkU4Wab83-3Sk8mc42__ZpD_sDDeJldw</recordid><startdate>19890501</startdate><enddate>19890501</enddate><creator>Lobel, J S</creator><creator>Cameron, B F</creator><creator>Johnson, E</creator><creator>Smith, D</creator><creator>Kalinyak, K</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19890501</creationdate><title>Value of screening umbilical cord blood for hemoglobinopathy</title><author>Lobel, J S ; Cameron, B F ; Johnson, E ; Smith, D ; Kalinyak, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c288t-22bbda7683970a42141054fb97820237b44a8b1eda8a4316dffe8726a80ca61f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Anemia, Sickle Cell - blood</topic><topic>Anemia, Sickle Cell - epidemiology</topic><topic>Anemia, Sickle Cell - mortality</topic><topic>Fetal Blood - analysis</topic><topic>Hemoglobin SC Disease - blood</topic><topic>Hemoglobin, Sickle - analysis</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Mass Screening</topic><topic>Ohio</topic><topic>Sickle Cell Trait - blood</topic><topic>Thalassemia - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lobel, J S</creatorcontrib><creatorcontrib>Cameron, B F</creatorcontrib><creatorcontrib>Johnson, E</creatorcontrib><creatorcontrib>Smith, D</creatorcontrib><creatorcontrib>Kalinyak, K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatrics (Evanston)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lobel, J S</au><au>Cameron, B F</au><au>Johnson, E</au><au>Smith, D</au><au>Kalinyak, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Value of screening umbilical cord blood for hemoglobinopathy</atitle><jtitle>Pediatrics (Evanston)</jtitle><addtitle>Pediatrics</addtitle><date>1989-05-01</date><risdate>1989</risdate><volume>83</volume><issue>5 Pt 2</issue><spage>823</spage><epage>826</epage><pages>823-826</pages><issn>0031-4005</issn><eissn>1098-4275</eissn><abstract>Foremost among the beneficial effects of screening umbilical cord blood is the optimized quality of care that can follow the immediate involvement of an infant with sickle cell disease and his or her family in an appropriate health care system. This is exemplified by the reduction in the case fatality rate of pneumococcal septicemia that has been achieved. Appropriate follow-up of screening also includes transmission of information about the diagnosis of a hemoglobinopathy trait or alpha-thalassemia to affected families and their physicians, with ready availability of education and counseling.</abstract><cop>United States</cop><pmid>2717309</pmid><doi>10.1542/peds.83.5.823</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0031-4005 |
| ispartof | Pediatrics (Evanston), 1989-05, Vol.83 (5 Pt 2), p.823-826 |
| issn | 0031-4005 1098-4275 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_78978362 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Anemia, Sickle Cell - blood Anemia, Sickle Cell - epidemiology Anemia, Sickle Cell - mortality Fetal Blood - analysis Hemoglobin SC Disease - blood Hemoglobin, Sickle - analysis Humans Infant, Newborn Mass Screening Ohio Sickle Cell Trait - blood Thalassemia - blood |
| title | Value of screening umbilical cord blood for hemoglobinopathy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T10%3A57%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Value%20of%20screening%20umbilical%20cord%20blood%20for%20hemoglobinopathy&rft.jtitle=Pediatrics%20(Evanston)&rft.au=Lobel,%20J%20S&rft.date=1989-05-01&rft.volume=83&rft.issue=5%20Pt%202&rft.spage=823&rft.epage=826&rft.pages=823-826&rft.issn=0031-4005&rft.eissn=1098-4275&rft_id=info:doi/10.1542/peds.83.5.823&rft_dat=%3Cproquest_cross%3E78978362%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78978362&rft_id=info:pmid/2717309&rfr_iscdi=true |